<DOC>
	<DOCNO>NCT02192320</DOCNO>
	<brief_summary>To evaluate Efficacy Safety oral Atorvastatin Dexamethasone conservative treatment Chronic Subdural Hematoma ( CSDH ) patient Coagulation Disorders</brief_summary>
	<brief_title>The Clinical Study Atorvastatin Dexamethasone Treatment Chronic Subdural Hematoma Patients With Coagulation Disorders</brief_title>
	<detailed_description>Study design : Two-arm , Evaluator-blinded study Subjects : CSDH patient Coagulation Disorders（Conservative treatment adopted） Sample size : 60 case , 30 Atorvastatin Dexamethasone-treated group , 30 Atorvastatin-treated group .</detailed_description>
	<mesh_term>Hematoma</mesh_term>
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<mesh_term>Hematoma , Subdural</mesh_term>
	<mesh_term>Hematoma , Subdural , Chronic</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>1 . Age ≥18 and＜90years old , gender ; 2 . Longterm antiplatelet anticoagulant drug cause Coagulation Disorders ; 3 . CT scan reveals supratentorial , unilateral bilateral chronic subdural hematoma ( MRI scan warrant diagnosis difficult ) ; 4 . The midline shift le 1 cm ; 5 . Attending physician make judgment cerebral hernia would occur surgical operation might perform short time . Conservative treatment adopt ; 6 . Patients never undergo surgery hematoma ; 7 . Patient fully understood nature study , voluntarily participate sign informed consent . 1 . Allergic statin dexamethasone ingredient ; 2 . Hematoma cause tumor , blood know comorbidities ; 3 . Abnormal liver function ; 4 . Uncontrolled hepatitis liver disease , well suffer disease may interfere study ; 5 . Patients oral Statin treatment past four week ; 6 . Patients oral Steroids treatment long time ; 7 . Diagnosed Diabetes patient poorly control blood glucose 8 . Participate clinical trial past four week ; 9 . Pregnant breastfeeding ; 10 . Failure complete trial poor compliance ; 11 . For reason , researcher believe case suitable inclusion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Atorvastatin</keyword>
	<keyword>Atorvastatin Dexamethasone</keyword>
	<keyword>Chronic Subdural Hematoma</keyword>
	<keyword>conservative treatment</keyword>
</DOC>